February 19, 2007
As evidence mounts that the body's normally protective inflammation response can drive some precancerous tissues to become fully malignant, UCSF scientists report discovering an apparent trigger to this potentially deadly process.
Typically, the "innate" immune system's Pac-Man-like white blood cells, or leukocytes, engulf and destroy ...
February 7, 2007
UCSF neurosurgeon Andrew Parsa, MD, PhD, is running a clinical trial on patients with glioblastoma multiforme, the most deadly type of brain tumor, using a vaccine made from the patient's own tumor to trigger the immune system.
In the clinical trial, Parsa first removes as ...
January 26, 2007
UCSF scientists are reporting key insights into the p53 tumor-suppressor gene that they say should help harness the gene to treat cancer.
The gene is disabled in most forms of the disease, and its loss is often associated with increased malignancy, resistance to treatment and ...
January 22, 2007
Mack Roach III, MD, professor of radiation oncology and urology, has been named chair of the Department of Radiation Oncology.
"Dr. Roach is recognized as one of America's leading authorities on the use of radiation to treat localized prostate cancer and as a prominent crusader ...
January 11, 2007
Due to aggressive prostate cancer screening, more men than ever before are being diagnosed with small, low-grade tumors that may pose little immediate threat.
Oncologists are offering some of these men close monitoring -- called active surveillance -- without any immediate treatment. Why not treat?
January 10, 2007
Many men with early-stage prostate cancers may be undergoing treatment unnecessarily with surgery or radiation, according to a leading prostate cancer surgeon.
Heads-up diagnosis and treatment have undoubtedly played an important role in decreasing deaths due to prostate cancer. But even so, "about half the ...